Strong evidence that HPV vaccination protects against cervical pre-cancer, review finds
There is strong evidence that vaccination against human papillomavirus (HPV) between the ages of 15 and 26 years protects against cervical pre-cancer in young women, concluded the authors of a recent Cochrane Review (9 May 2018).
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Drugs & Pharmacology | Genital Warts | Human Papillomavirus (HPV) | Vaccines | Women